|
321 |
New drugs under clinical stage |
Download (21.96 KB)  |
30/06/2014 |
|
322 |
DRL to develop products for integrated markets |
Download (74.5 KB) |
30/06/2014 |
|
323 |
Ranbaxy gets nod for new generic BP drug |
Download (35.7 KB) |
28/06/2014 |
|
324 |
Zydus loses 2 popular brands |
Download (60.03 KB) |
28/06/2014 |
|
325 |
Piramal arm recalls 2,052 glass vials of drug in US |
Download (26.01 KB) |
28/06/2014 |
|
326 |
Ranbaxy gets USFDA nod to Diovan is USA |
Download (29.07 KB) |
28/06/2014 |
|
327 |
Ranbaxygets USFDA nod to sell generic Diovan in US |
Download (32.4 KB) |
28/06/2014 |
|
328 |
DRL plans RS. 800-cr biologics spend before US, Europe foray |
Download (109.63 KB) |
26/06/2014 |
|
329 |
Astra Zeneca delisting process under market regulator lens |
Download (59.63 KB) |
25/06/2014 |
|
330 |
Cipla betting big on talent for future growth |
Download (43.5 KB) |
25/06/2014 |
|
331 |
Cipla mulls new health care fund |
Download (40.3 KB) |
23/06/2014 |
|
332 |
DRL recalls 13,560 bottles of hypertension drug: FDA |
Download (27.19 KB) |
20/06/2014 |
|
333 |
Glivec Patent Battle loss behind Us: Novartis Shahani |
Download (42.7 KB) |
19/06/2014 |
|
334 |
Hilleman labs in talks to market next-gen oral cholera vaccine |
Download (41.67 KB) |
19/06/2014 |
|
335 |
Cipla drug pipeline turns it into $10-bn target |
Download (64.78 KB) |
19/06/2014 |
|
336 |
As Actavis business im proves, Aurobindo sees early turnaround |
Download (64.07 KB) |
18/06/2014 |
|
337 |
Lupin launches generic drug in US |
Download (26.06 KB) |
14/06/2014 |
|
338 |
Dr Reddy unvells melgain lotion |
Download (21.34 KB) |
14/06/2014 |
|
339 |
DRL eyes dermatology segmetn in bid to boost market share |
Download (31.58 KB) |
13/06/2014 |
|
340 |
Jubilant life hikes Vitamin B3 product price |
Download (21.61 KB) |
13/06/2014 |
औषध विभाग
Department of
